These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Indications for non-steroidal anti-inflammatory agents]. Bisson M, Couzinet B, Hiesse C, Le Pajolec C. Rev Prat; 1987 Oct 15; 37(41):2500-6. PubMed ID: 3500498 [No Abstract] [Full Text] [Related]
23. [The limits of our therapeutical possibilities in rheumatic diseases (author's transl)]. Trnavský K. Cas Lek Cesk; 1978 Jul 28; 117(29-30):889-92. PubMed ID: 308392 [No Abstract] [Full Text] [Related]
24. [What shall we do with the numerous new anti-rheumatics?]. Hvidberg E. Ugeskr Laeger; 1981 Apr 13; 143(16):1040-3. PubMed ID: 6972112 [No Abstract] [Full Text] [Related]
25. [NSAIDs: a clinical pharmacological determination of their role in the drug treatment of rheumatic disorders]. van Riel PL. Ned Tijdschr Geneeskd; 1988 Nov 26; 132(48):2187-92. PubMed ID: 3264601 [No Abstract] [Full Text] [Related]
26. [Ground rules in pharmacotherapy of rheumatic diseases]. Wessel G, Reinicke C. Z Gesamte Inn Med; 1980 Nov 15; 35(22):suppl 157-60. PubMed ID: 6970456 [No Abstract] [Full Text] [Related]
27. [What are the indications for non-steroidal anti-inflammatory agents in dermatology?]. Bonnetblanc JM. Ann Dermatol Venereol; 1999 Nov 15; 126(8-9):649-52. PubMed ID: 10530363 [No Abstract] [Full Text] [Related]
28. [Workshop 88. Perspectives on topical therapy using non-steroidal antiphlogistics/analgesics. Frankfurt/Main, 23 January 1988]. Z Rheumatol; 1988 Nov 15; 47(6 Suppl):1-12. PubMed ID: 3265560 [No Abstract] [Full Text] [Related]
29. Anesthesia and postanesthetic considerations. Jackson S, Singleton M, Silcox D, Jackson E. Clin Podiatr Med Surg; 1988 Jan 15; 5(1):169-92. PubMed ID: 2962718 [Abstract] [Full Text] [Related]
30. Cardiological manifestations of the rheumatic diseases. Cardoe N. Practitioner; 1978 Jan 15; 220(1315):75-8. PubMed ID: 305043 [No Abstract] [Full Text] [Related]
31. [Nonsteroidal antirheumatics in soft tissue rheumatic diseases. Scientific background and differential therapy. 5th Rottach-Egern rheumatism discussion. 26 November 1988. Abstracts]. Fortschr Med Suppl; 1989 Jan 15; 60():1-11. PubMed ID: 2786832 [No Abstract] [Full Text] [Related]
33. I've been diagnosed with palindromic rheumatism. It seems to come and go a lot. What is it and how can I treat it? Duke Med Health News; 2007 Dec 06; 13(12):12. PubMed ID: 18290263 [No Abstract] [Full Text] [Related]
34. Modern drug therapy in rheumatic diseases. Molony J. Ir Med J; 1975 Jun 06; Suppl():36-7. PubMed ID: 1081096 [No Abstract] [Full Text] [Related]
35. The cardiovascular manifestations of rheumatic diseases. Goodson NJ, Solomon DH. Curr Opin Rheumatol; 2006 Mar 06; 18(2):135-40. PubMed ID: 16462518 [Abstract] [Full Text] [Related]
36. Pharmacogenetics in the rheumatic diseases, from prêt-à-porter to haute couture. Cronstein BN. Nat Clin Pract Rheumatol; 2006 Jan 06; 2(1):2-3. PubMed ID: 16932642 [No Abstract] [Full Text] [Related]
37. Phosphodiesterase inhibitor pentoxifylline: an antiinflammatory/immunomodulatory drug potentially useful in some rheumatic diseases. Anaya JM, Espinoza LR. J Rheumatol; 1995 Apr 06; 22(4):595-9. PubMed ID: 7791149 [No Abstract] [Full Text] [Related]